Atsuko Ogino

A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors

Takaaki Sasaki, Jussi Koivunen, Atsuko Ogino et al. · Cancer Research · 2011 · 599 citations · Full text

Immunology, Anaplastic Lymphoma Kinase, Tumor Biology +16

Clinical, Pathologic, and Biologic Features Associated with <i>BRAF</i> Mutations in Non–Small Cell Lung Cancer

Stephanie Cardarella, Atsuko Ogino, Mizuki Nishino et al. · Clinical Cancer Research · 2013 · 367 citations · Full text

Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i> -Mutant Lung Cancer

Erin M. Tricker, Chunxiao Xu, Sharmeen Uddin et al. · Cancer Discovery · 2015 · 218 citations · Full text

Emergence of Epidermal Growth Factor Receptor T790M Mutation during Chronic Exposure to Gefitinib in a Non–Small Cell Lung Cancer Cell Line

Atsuko Ogino, Hiroyuki Kitao, Seiki Hirano et al. · Cancer Research · 2007 · 195 citations · Full text

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Ciric To, Tyler S. Beyett, Jaebong Jang et al. · Nature Cancer · 2022 · 146 citations · Full text

Therapy-resistant Mutant Forms, Medicine, Pharmacology +9